| 标题 |
LBA1 Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with high-risk human epidermal growth factor receptor 2–positive (HER2+) primary breast cancer (BC) with residual invasive disease after neoadjuvant therapy (tx): Interim analysis of DESTINY-Breast05 |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:C.E. Geyer; Y.H. Park; Z-M. Shao; C-S. Huang; C.H.E. Barrios; et al 出版日期:2025-11-20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)